Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
GMAB
GMAB
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
GMAB News
Genmab Major Shareholder Announcement
5d ago
Newsfilter
Genmab Reports Positive Clinical Trial Results for Epcoritamab
6d ago
NASDAQ.COM
Epcoritamab Shows Significant Efficacy in Elderly DLBCL Patients
Jun 13 2026
Newsfilter
New Data on Epcoritamab Combination Therapy for Lymphoma Released
Jun 11 2026
Newsfilter
Latest Wall Street Rating Updates
May 26 2026
CNBC
Genmab Major Shareholder Announcement
May 08 2026
Newsfilter
Genmab Reports 25% Revenue Growth in Q1
May 07 2026
seekingalpha
Genmab to Announce Q1 Earnings on May 7
May 06 2026
seekingalpha
Latest Rating Changes on Wall Street
Apr 22 2026
CNBC
Genmab Major Shareholder Announcement
Apr 14 2026
Newsfilter
Genmab's DARZALEX Global Sales Reach $3.96 Billion
Apr 14 2026
seekingalpha
Genmab Reports $3.964 Billion DARZALEX® Sales in Q1 2026
Apr 14 2026
Newsfilter
Safety Study of Rina-S and Bevacizumab Combination Therapy
Apr 13 2026
Newsfilter
Corbus Secures FDA Alignment on CRB-701 Pathway
Apr 07 2026
Newsfilter
Genmab Major Shareholder Announcement
Mar 30 2026
Newsfilter
Investment Opportunities in Oversold Healthcare Stocks
Feb 19 2026
Benzinga
Show More News
